Whole blood assays for interferon-gamma: practicalities and potential for use as diagnostic tests in the field

H M Dockrell1, G F Black, R E Weir

  • 1Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.

Leprosy Review
|February 24, 2001
PubMed

Insights

Whole-blood assays offer a robust method for assessing T-cell responses to antigens. These immunodiagnostic tools show promise for diagnosing leprosy and measuring Mycobacterium leprae exposure.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Diagnostic Assays

Background:

  • Whole-blood assays stimulate heparinized blood with antigens to measure cytokine production.
  • These assays require small blood samples and basic laboratory facilities, making them suitable for field use.

Purpose of the Study:

  • To evaluate the robustness and applicability of whole-blood assays for assessing T-cell responses.
  • To explore the potential of these assays in diagnosing leprosy and monitoring Mycobacterium leprae exposure.

Main Methods:

  • Utilized diluted blood, 6-day whole-blood assays in a large study of BCG vaccination effects.
  • Measured cytokine production in plasma or supernatant after antigen stimulation.

Main Results:

  • The 6-day whole-blood assay demonstrated robustness in assessing T-cell responses to various antigens.
  • The assay is effective for both crude and recombinant antigens.

Conclusions:

  • Whole-blood assays are reliable for evaluating T-cell immunity.
  • These assays can be adapted for diagnosing leprosy and assessing M. leprae exposure in populations.

Related Concept Videos